Loss of heterozygosity of key tumor suppressor genes in advanced renal cancer patients treated with nivolumab

被引：3

作者：

Bersanelli, Melissa ^{[1
]}

Gnetti, Letizia ^{[2
]}

Azzoni, Cinzia ^{[2
]}

Bottarelli, Lorena ^{[2
]}

Sverzellati, Nicola ^{[3
]}

Campanini, Nicoletta ^{[2
]}

Varotti, Elena ^{[2
]}

Corrado, Michele ^{[3
]}

Parziale, Raffaele ^{[3
]}

Rapacchi, Elena ^{[1
]}

Caruso, Giuseppe ^{[1
]}

Leonardi, Francesco ^{[1
]}

Silini, Enrico Maria ^{[2
]}

Buti, Sebastiano ^{[1
]}

机构：

[1] Univ Hosp Parma, Med Oncol, Via Gramsci 14, I-43126 Parma, Italy

[2] Univ Hosp Parma, Pathol Anat Unit, Via Gramsci 14, I-43126 Parma, Italy

[3] Univ Hosp Parma, Radiol Unit, Via Gramsci 14, I-43126 Parma, Italy

来源：

IMMUNOTHERAPY | 2018年 / 10卷 / 09期

关键词：

FHIT; loss of heterozygosity; renal cell carcinoma; SPORADIC BREAST-CANCER; CLEAR-CELL CARCINOMA; MISMATCH-REPAIR; MICROSATELLITE INSTABILITY; OVARIAN-CANCER; BRCA2; VHL; 3P; TUMORIGENESIS; GUIDELINES;

D O I：

10.2217/imt-2017-0160

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Aim: We studied the possible clinical significance of loss of heterozygosity (LOH) at key tumor suppressor genes loci in advanced renal cancer patients treated with nivolumab. Methods: LOH study was performed on 3p14.2 (FHIT gene); 3p21.3-21.2; 9p21 (BDMF gene); 9p22 (SH3GL2 gene). Results: Of 12 patients, 8 (67%) had LOH. The most affected gene was FHIT. All five patients with LOH at FHIT locus had good outcome, mean progression free survival of 6.8 months. The patients LOH negative at FHIT locus had mean progression free survival of 4 months, 67% were treatment refractory. Overall, 75% of patients with LOH of at least one gene had benefit; 75% of LOH negative cases were refractory. Conclusion: LOH at key tumor suppressor genes should be further investigated as predictive for immunotherapy.

引用

页码：743 / +

页数：11

共 50 条

[11] TUMOR SUPPRESSOR GENES - A KEY TO THE CANCER PUZZLE
OPPENHEIMER, SB
AMERICAN BIOLOGY TEACHER, 1991, 53 (01): : 22 - 24
[12] LOSS OF HETEROZYGOSITY (LOH) PUTATIVE TUMOR SUPPRESSOR GENES LOCI IN LOCALLY METASTATIC PROSTATE-CANCER
SAKR, WA
MACOSKA, J
BENSON, P
PONTES, JE
CRISSMAN, JD
WOLMAN, SR
LABORATORY INVESTIGATION, 1993, 68 (01) : A68 - A68
[13] Frequent occurrence of loss of heterozygosity among tumor suppressor genes in uterine leiomyosarcoma
Zhai, YL
Nikaido, T
Orii, A
Horiuchi, A
Toki, T
Fujii, S
GYNECOLOGIC ONCOLOGY, 1999, 75 (03) : 453 - 459
[14] Frequent somatic gene conversion as a mechanism for loss of heterozygosity in tumor suppressor genes
Takahashi, Kazuki K.
Innan, Hideki
GENOME RESEARCH, 2022, 32 (06) : 1017 - 1025
[15] LOSS OF HETEROZYGOSITY INVOLVES MULTIPLE TUMOR SUPPRESSOR GENES IN HUMAN ESOPHAGEAL CANCERS
HUANG, Y
BOYNTON, RF
BLOUNT, PL
SILVERSTEIN, RJ
YIN, J
TONG, Y
MCDANIEL, TK
NEWKIRK, C
RESAU, JH
SRIDHARA, R
REID, BJ
MELTZER, SJ
CANCER RESEARCH, 1992, 52 (23) : 6525 - 6530
[16] Allelic loss analysis of tumor suppressor genes regardless of heterozygosity: von Hippel-Lindau gene loss in renal cell carcinoma
Mochida, Jun'ichi
Esumi, Mariko
Kitajima, Akiko
Okada, Kiyoki
JOURNAL OF UROLOGY, 2008, 180 (02): : 724 - 728
[17] Loss of heterozygosity of selected tumor suppressor genes in human testicular germ cell tumors
Vladusic, Tomislav
Hrascan, Reno
Vrhovac, Ivana
Kruslin, Bozo
Gamulin, Marija
Grgic, Mislav
Pecina-Slaus, Nives
Colic, Jasna Franekic
PATHOLOGY RESEARCH AND PRACTICE, 2010, 206 (03) : 163 - 167
[18] Loss of heterozygosity of tumor suppressor genes in cytologically atypical areas in Hashimoto's thyroiditis
Hunt, JL
Baloch, Z
Barnes, EL
Swalsky, PA
Trusky, CL
Sasatomi, E
Finkelstein, S
LiVolsi, VA
MODERN PATHOLOGY, 2002, 15 (01) : 116A - 116A
[19] Age-associated loss of heterozygosity of tumor suppressor genes in the gastric mucosa of humans
Moragoda, L
Jaszewski, R
Kulkarni, P
Majumdar, APN
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2002, 282 (06): : G932 - G936
[20] Folic acid mediated prevention of loss of heterozygosity of tumor suppressor genes in colorectal adenomas
Nagothu, K
Jaszewski, R
Moragoda, L
Rishi, AK
Majumdar, APN
GASTROENTEROLOGY, 2002, 122 (04) : A214 - A214

← 1 2 3 4 5 →